Improvement in median overall survival of 2.9 months and decrease in risk for death reported with elraglusib/GnP vs GnP alone.
Trends in incidence and survival in anal adenocarcinoma: A SEER study of racial and age disparities.
Trends and disparities in palliative care utilization among patients with anal cancer: A ten-year retrospective study. This table summarizes the key trends in anal adenocarcinoma incidence and ...
Investigators compared cancer-specific survival rates after synchronous vs metachronous metastasis in patients with surgically treated renal cell carcinoma (RCC).
PolyPEPI1018 Cancer Vaccine and TAS-102 for Patients With Advanced, Chemo-Refractory, Microsatellite-Stable Metastatic Colorectal Cancer: A Phase Ib Nonrandomized Study Using SEER 22 data, we analyzed ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results